Amarin | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amarin USD 305.2M 156K 2024-09
AstraZeneca USD 388M 0 2024-12
DBV Technologies USD 10.98M 1000 2024-09
GlaxoSmithKline GBP 1.35B 0 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12



Amarin Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.